The discovery of cisplatin (cis-Pt (NH 3) 2 Cl 2) as an antineoplastic agent has focussed attention on the rational design of metal complexes that can be potentially used in cancer …
MG Ferraro, M Piccolo, G Misso, R Santamaria, C Irace - Pharmaceutics, 2022 - mdpi.com
Countless expectations converge in the multidisciplinary endeavour for the search and development of effective and safe drugs in fighting cancer. Although they still embody a …
Highlights•TNBC is an unmet medical need with poor survival rates and no targeted therapy.•TNBC resists conventional chemotherapy and surgical strategies.•A review of 121 …
The main purpose of this article is to focus on the diversity created by substitution on pyridine rings of 2, 2′: 6′, 2 ″-terpyridines (tpy) allowing a fine-tuning of the ligand …
This article provides a comprehensive review of palladium compounds that have been evaluated for anticancer activity in vivo or in vitro from the era of discovery of cisplatin up to …
N Nayeem, M Contel - Chemistry–A European Journal, 2021 - Wiley Online Library
This review focuses on studies of coordination and organometallic compounds as potential chemotherapeutics against triple negative breast cancer (TNBC) which has one of the …
Terpyridine complexes are known for their broad biological activities, of which their anticancer potency is the most extensively studied. Strikingly, free ligand activity has rarely …
Based on the chemotherapeutic success of cisplatin, carboplatin and oxaliplatin as anticancer drugs, and silver sulfadiazine (AgSDZ) as an antibacterial drug, exploration of the …
The use of cisplatin and its derivatives in cancer treatment triggered the interest in metal- containing complexes as potential novel anticancer agents. Palladium (II)-based complexes …